Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
STRONG BUY! Kurs eskaliert - A Star is Born!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
562 Leser
Artikel bewerten:
(2)

Persistent Systems: Persistent Appoints Vinit Teredesai as Chief Financial Officer

Finanznachrichten News

SANTA CLARA, Calif. and PUNE, India, May 15, 2024 /PRNewswire/ --

News Summary

Persistent Systems (BSE: PERSISTENT) (NSE: PERSISTENT) announced today the appointment of Vinit Teredesai as the Chief Financial Officer (CFO) of the Company, effective immediately, taking over from Sunil Sapre, Executive Director, who will be retiring later this year. Vinit will be responsible for providing financial leadership to Persistent in its continuing growth journey.

Persistent_Systems_Logo

Vinit is a seasoned finance professional with over 28 years of experience in finance, accounting, auditing, taxation, fund raising, risk management, mergers and acquisitions, and corporate restructuring. Earlier, he served as the CFO at LTIMindtree Limited, and before that, of Mindtree Limited. Prior, he worked as the CFO and CIO of KPIT Technologies Limited. Vinit is a qualified Chartered Accountant, Cost and Management Accountant, and a Certified Public Accountant in the United States. He has completed a General Management program from the Sloan School of Management at the Massachusetts Institute of Technology (MIT), focusing on strategy, innovation, and technology.

Sandeep Kalra, Chief Executive Officer and Executive Director, Persistent:

"It's my pleasure to welcome Vinit to the Persistent team. Vinit's rich industry experience and expertise in the finance domain will be a valuable addition to the executive team in the next orbit of our growth journey to $2 billion in revenue and beyond, while ensuring the creation of enhanced stakeholder value. I would also like to thank Sunil for his valuable contribution to Persistent over the past 9 years. Sunil will continue to be a key part of Persistent executive team and our board till his retirement later this year."

Sunil Sapre, Former Chief Financial Officer and Executive Director, Persistent:

"I am very happy to welcome Vinit and wish him the best as he steps in as the next CFO of the Company. I will be working closely with him to ensure a smooth transition. I would like to express my deepest gratitude to our Board for the trust placed in me, and for their support, and guidance throughout my tenure as CFO. In addition, I would like to express my sincere thanks to our customers, partners, investors, analysts, vendors, and other stakeholders for their support through this journey."

About Persistent
With over 23,800 employees located in 21 countries, Persistent Systems (BSE & NSE: PERSISTENT) is a global services and solutions company delivering Digital Engineering and Enterprise Modernization. As a participant of the United Nations Global Compact, Persistent is committed to aligning strategies and operations with universal principles on human rights, labor, environment, and anti-corruption, as well as take actions that advance societal goals. With 268% growth since 2020, Persistent is the fastest-growing Indian IT Services brand according to Brand Finance.
www.persistent.com

Forward-looking and Cautionary Statements
For risks and uncertainties relating to forward-looking statements, please visit persistent.com/flcs

Logo: https://mma.prnewswire.com/media/1022385/4436045/Persistent_Systems_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/persistent-appoints-vinit-teredesai-as-chief-financial-officer-302146729.html

© 2024 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.